Siemens Medical Solutions Recalls NAEOTOM Alpha.Pro Software Applications Due to Lack of FDA Clearance
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Siemens Medical Solutions USA, Inc. has issued a voluntary recall for specific NAEOTOM Alpha.Pro software applications that have not received required FDA 510(k) clearance.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Siemens Medical Solutions USA, Inc. has initiated a voluntary recall of specific software applications associated with the NAEOTOM Alpha.Pro CT systems. The recall was launched because the applications—syngo.CT Brain Quantification, syngo.CT Vessel Hyperdensities, and syngo.CT ASPECTS—were distributed without receiving the necessary FDA 510(k) clearance.
Which Products Are Affected
The recall involves two units of the NAEOTOM Alpha.Pro software applications. Affected products are identified by the following details:
- Product Names: syngo.CT Brain Quantification, syngo.CT Vessel Hyperdensities, syngo.CT ASPECTS
- Material Number: 10191100
- UDI-DI: 04068151014655
- Serial Numbers: 258043, 258055
- Recall Number: Z-1242-2026
- Distribution: Worldwide distribution, including the United States, Canada, Costa Rica, India, and Israel.
What You Should Do
Siemens Medical Solutions USA, Inc. notified affected customers via a formal letter. The primary action required is the removal of the specified software applications from the CT systems. Facilities possessing these serial numbers should follow the instructions provided in the firm's notification letter to ensure the uncleared software is decommissioned.
Why This Matters
This recall is necessary to ensure that all medical software used in clinical diagnostic settings has undergone the rigorous FDA review process required to verify its safety and effectiveness for patient care.
Source
Information provided by the FDA.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.